Our Pricing

Cheapest Place to Buy Wegovy UK: Price Comparison and Online Prescription Guide

Published on: June 03, 2026

Finding the cheapest place to buy Wegovy UK doesn't mean compromising on quality or safety. At Cured Pharmacy, you'll access genuine UK-licensed Wegovy (semaglutide) from £79.00, with transparent upfront pricing, a free online consultation under three minutes, and discreet next-day delivery—all overseen by our superintendent pharmacist Tarun Kumar (GPhC 2233073).

Why Wegovy Prices Vary Across UK Pharmacies

Wegovy pricing in the UK fluctuates significantly between pharmacies due to differing supply agreements, consultation models, and operational overheads. At Cured Pharmacy, we guarantee the lowest prices in the UK by streamlining our digital consultation process and negotiating directly with licensed wholesalers, passing savings directly to patients.

Unlike traditional pharmacies that bundle hidden fees into consultation charges or delivery costs, we display the full treatment price upfront—before you complete your clinical assessment. This transparency ensures you're comparing like-for-like when evaluating the cheapest place to buy Wegovy UK, with no surprise charges at checkout.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities [1]. Semaglutide mimics the natural GLP-1 hormone, slowing gastric emptying, reducing appetite, and enhancing feelings of fullness after meals.

In the landmark STEP 1 trial, participants using Wegovy achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. At week 20, 86% of patients on semaglutide 2.4 mg achieved at least 5% weight loss, with 69% losing 10% or more [2]. These results position Wegovy as one of the most effective pharmacological weight loss treatments available in the UK today.

Clinical Evidence Supporting Semaglutide

The STEP trial programme enrolled over 4,500 participants across five global studies, demonstrating consistent efficacy and safety profiles [1][2]. Participants combined Wegovy with reduced-calorie diets and increased physical activity, reflecting the medication's role as part of a comprehensive weight management programme rather than a standalone solution. Your UK prescriber will assess whether Wegovy aligns with your medical history, current medications, and weight loss goals during your free consultation.

Wegovy Dosing Schedule and Treatment Timeline

Wegovy follows a gradual dose-escalation protocol over 16 to 20 weeks, starting at 0.25 mg once weekly and increasing monthly to the maintenance dose of 2.4 mg [3]. This titration schedule minimises gastrointestinal side effects—the most common adverse reactions reported in clinical trials—by allowing your body to adapt to increasing semaglutide levels.

Each Wegovy pen is pre-filled for single use, injected subcutaneously into the abdomen, thigh, or upper arm. Most patients find the injection process straightforward after the first dose, and our clinical team provides detailed administration guidance alongside your prescription. Treatment duration varies by individual response, but clinical trials evaluated Wegovy over 68 weeks, with many patients continuing beyond this period subject to ongoing prescriber review [1].

What to Expect During Dose Escalation

Nausea, diarrhoea, and constipation are most common during the initial escalation phases and typically subside as your body adjusts [3]. Staying well-hydrated, eating smaller meals, and avoiding high-fat foods can help manage these effects. If side effects persist or worsen, contact your prescriber—they may recommend slowing the titration or adjusting your treatment plan.

Wegovy vs Other Weight Loss Treatments: What's the Difference?

Wegovy is one of several GLP-1 receptor agonists licensed for weight management in the UK, each with distinct mechanisms, dosing schedules, and clinical outcomes. Saxenda (liraglutide) requires daily injections and demonstrated average weight loss of 8% in trials—effective, but less than Wegovy's 14.9% [4]. Mounjaro (tirzepatide), a dual GIP/GLP-1 receptor agonist, showed average weight reductions up to 22.5% in the SURPASS-3 trial, though it remains primarily licensed for type 2 diabetes in the UK [5].

Non-injectable options like Orlistat and Mysimba offer alternatives for patients who prefer oral medications. Orlistat blocks dietary fat absorption and produces average weight loss of 5-10% when combined with a low-fat diet, while Mysimba (naltrexone/bupropion) acts on central appetite pathways [6]. Your UK prescriber will recommend the most suitable treatment based on your BMI, medical history, previous weight loss attempts, and personal preferences.

Who Can Use Wegovy? Eligibility and Contraindications

Wegovy is licensed for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [3]. It is not suitable for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

Pregnant or breastfeeding women should not use Wegovy, and those planning pregnancy should discontinue treatment at least two months before conception due to the medication's long half-life [3]. Your online consultation at Cured Pharmacy includes a comprehensive medical screening to identify any contraindications, ensuring Wegovy is safe and appropriate for you before a UK prescriber issues a prescription.

Common Questions About Eligibility

Patients often ask whether previous weight loss attempts are required before starting Wegovy. While NICE guidelines recommend lifestyle interventions first, many online pharmacies—including Cured Pharmacy—assess eligibility on an individual basis, considering your full medical history and circumstances. If you have type 2 diabetes, your prescriber will evaluate whether Wegovy or an alternative GLP-1 agonist better suits your glycaemic control needs.

How to Buy Wegovy Online Safely in the UK

Purchasing Wegovy online requires a valid prescription from a UK-registered prescriber, as semaglutide is a prescription-only medicine regulated by the MHRA. At Cured Pharmacy, the process takes under three minutes: complete a confidential online consultation, receive a clinical review by our UK prescribers, and—if approved—your prescription is dispensed by our GPhC-registered pharmacy (9012511) and dispatched in discreet packaging.

Beware of websites offering Wegovy without a consultation or from unregulated sources outside the UK. Counterfeit semaglutide products have been identified in the UK market, posing serious health risks including incorrect dosing, contamination, and absence of active ingredients [7]. Always verify the pharmacy is GPhC-registered and that a qualified UK prescriber reviews your medical information before dispensing any prescription medication.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management (CG189). Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
7. Medicines and Healthcare products Regulatory Agency. (2023). Falsified Ozempic (semaglutide) pre-filled pens identified in the UK. Drug Safety Update, 16(10). Retrieved from https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to a reduced-calorie diet and increased physical activity alongside medication use.